Style | Citing Format |
---|---|
MLA | Sheibani M, et al.. "Insulin Signaling Pathway Model in Adipocyte Cells." Current Pharmaceutical Design, vol. 29, no. 1, 2023, pp. 37-47. |
APA | Sheibani M, Jalalifarahani F, Zarghami R, Sadrai S (2023). Insulin Signaling Pathway Model in Adipocyte Cells. Current Pharmaceutical Design, 29(1), 37-47. |
Chicago | Sheibani M, Jalalifarahani F, Zarghami R, Sadrai S. "Insulin Signaling Pathway Model in Adipocyte Cells." Current Pharmaceutical Design 29, no. 1 (2023): 37-47. |
Harvard | Sheibani M et al. (2023) 'Insulin Signaling Pathway Model in Adipocyte Cells', Current Pharmaceutical Design, 29(1), pp. 37-47. |
Vancouver | Sheibani M, Jalalifarahani F, Zarghami R, Sadrai S. Insulin Signaling Pathway Model in Adipocyte Cells. Current Pharmaceutical Design. 2023;29(1):37-47. |
BibTex | @article{ author = {Sheibani M and Jalalifarahani F and Zarghami R and Sadrai S}, title = {Insulin Signaling Pathway Model in Adipocyte Cells}, journal = {Current Pharmaceutical Design}, volume = {29}, number = {1}, pages = {37-47}, year = {2023} } |
RIS | TY - JOUR AU - Sheibani M AU - Jalalifarahani F AU - Zarghami R AU - Sadrai S TI - Insulin Signaling Pathway Model in Adipocyte Cells JO - Current Pharmaceutical Design VL - 29 IS - 1 SP - 37 EP - 47 PY - 2023 ER - |